Form 4 for NPCE NeuroPace Inc
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-27 · accession 0001209191-24-004087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-28 | 2024-02-27 | NPCE | Becker Joel | CEO, Dir | A - Grant | $0.00 | +52.5K | 52.5K | New | $0 |
| D | 2024-02-28 | 2024-02-27 | NPCE | Becker Joel | CEO, Dir | A - Grant | $0.00 | +104.7K | 104.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | A | A | 52,470 | $0.00 | 52,470 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 27, 2025 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-27 | A | A | 104,720 | $0.00 | 104,720 | D | $17.11 · — to 2034-02-26 | 104,720 Common Stock | (F2) 25% of the shares subject to the option vest on February 27, 2025. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |